Medizinische Universität Graz Austria/Österreich - Forschungsportal - Medical University of Graz
Kreuzer Philipp |
** = Publikationen gelistet in SCI/SSCI/Pubmed
2025
Übersichtsarbeit
** Hatzl, S; Posch, F; Scholz, L; Geiger, C; Kriegl, L; Kreuzer, P; Eller, P; Giacobbe, DR; Bassetti, M; Hoenigl, M; Krause, R
Comparative efficacy and safety of treatment regimens for Pneumocystis jirovecii pneumonia in people living with HIV: a systematic review and network meta-analysis of randomized controlled trials.
Clin Microbiol Infect. 2024;
Doi: 10.1016/j.cmi.2024.12.024
Web of Science
PubMed
FullText
FullText_MUG
Kommentar
** Kreuzer, P; Hatzl, S
Comment on: Prehospital interventions and outcomes in traumatic cardiac arrest: a population-based cohort study using Danish helicopter emergency medical services data.
Eur J Emerg Med. 2025; 32(2): 149
Doi: 10.1097/MEJ.0000000000001191
Web of Science
PubMed
FullText
FullText_MUG
2024
Originalarbeit (Zeitschrift)
** Hatzl, S; Geiger, C; Kriegl, L; Scholz, L; Reisinger, AC; Kreuzer, P; Fruhwald, S; Wölfler, A; Reinisch, A; von, Lewinski, D; Schilcher, G; Hoenigl, M; Eller, P; Krause, R
Performance of diagnostic algorithms in patients with invasive pulmonary aspergillosis.
Clin Infect Dis. 2024;
Doi: 10.1093/cid/ciae633
Web of Science
PubMed
FullText
FullText_MUG
** Scholz, L; Posch, F; Schulz, E; Gornicec, M; Wölfler, A; Reisinger, AC; Reinisch, A; Eller, P; Eisner, F; Kreuzer, P; Stradner, M; Rosenkranz, AR; Krammer, F; Schilcher, G; Krause, R; Hatzl, S
Ruxolitinib, IV Immunoglobulin, and High-Dose Glucocorticoids for Critically Ill Adults With Secondary Hemophagocytic Lymphohistiocytosis: A Single-Center Observational Pilot Study.
Crit Care Explor. 2024; 6(2): e1046
Doi: 10.1097/CCE.0000000000001046
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
2023
Originalarbeit (Zeitschrift)
** Santner, V; Riepl, HS; Posch, F; Wallner, M; Rainer, PP; Ablasser, K; Kolesnik, E; Hoeller, V; Zach, D; Schwegel, N; Kreuzer, P; Lueger, A; Petutschnigg, J; Pieske, B; Zirlik, A; Edelmann, F; Verheyen, N
Non-eligibility for pivotal HFpEF/HFmrEF outcome trials and mortality in a contemporary heart failure cohort.
Eur J Intern Med. 2023; 118:73-81
Doi: 10.1016/j.ejim.2023.07.027
Web of Science
PubMed
FullText
FullText_MUG